# PACIRA BIOSCIENCES, INC. (PCRX) FY2026 Q2 P&L / Income Statement

- Company: PACIRA BIOSCIENCES, INC. (PCRX)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001628280-26-052635
- Page: https://plicit.ai/financials/pcrx/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/pcrx-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service (5 categories)

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (5 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 192,399,000 US dollars
- **Cost of goods sold (exclusive of amortization of acquired intangible assets)**: 44,164,000 US dollars
- **Gross profit (calculated)**: 148,235,000 US dollars
- **Operating expenses (calculated)**: 143,968,000 US dollars
- **Income from operations**: 4,267,000 US dollars
- **Total other expense, net**: negative 1,712,000 US dollars
- **Income (loss) before income taxes**: 2,555,000 US dollars
- **Income tax benefit (expense)**: negative 2,098,000 US dollars
- **Net income (loss)**: 4,653,000 US dollars
- **EXPAREL**: 147,823,000 US dollars
- **ZILRETTA**: 32,648,000 US dollars
- **iovera°**: 6,806,000 US dollars
- **Bupivacaine liposome injectable suspension**: 3,216,000 US dollars
- **Royalty revenue**: 1,906,000 US dollars
- **Research and development**: 30,243,000 US dollars
- **Selling, general and administrative**: 91,809,000 US dollars
- **Amortization of acquired intangible assets**: 14,322,000 US dollars
- **Other operating expenses, net**: 7,594,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2 categories)

- Page: https://plicit.ai/financials/pcrx/fy2026-q2-income-statement/revenue-by-product-and-service-2-categories
- Chart image: https://plicit.ai/charts/pcrx-fy2026-q2-revenue-by-product-and-service-2-categories-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 192,399,000 US dollars
- **Cost of goods sold (exclusive of amortization of acquired intangible assets)**: 44,164,000 US dollars
- **Gross profit (calculated)**: 148,235,000 US dollars
- **Operating expenses (calculated)**: 143,968,000 US dollars
- **Income from operations**: 4,267,000 US dollars
- **Total other expense, net**: negative 1,712,000 US dollars
- **Income (loss) before income taxes**: 2,555,000 US dollars
- **Income tax benefit (expense)**: negative 2,098,000 US dollars
- **Net income (loss)**: 4,653,000 US dollars
- **Net product sales**: 190,493,000 US dollars
- **Royalty revenue**: 1,906,000 US dollars
- **Research and development**: 30,243,000 US dollars
- **Selling, general and administrative**: 91,809,000 US dollars
- **Amortization of acquired intangible assets**: 14,322,000 US dollars
- **Other operating expenses, net**: 7,594,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.